Shell Asset Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$72K Sell
4,212
-5,084
-55% -$72.8K 0.01% 757
2025
Q2
$117K Sell
9,296
-2,805
-23% -$33.4K ﹤0.01% 961
2025
Q1
$144K Sell
12,101
-256
-2% -$3.49K 0.01% 910
2024
Q4
$181K Hold
12,357
0.01% 874
2024
Q3
$155K Buy
+12,357
New +$135K 0.01% 929
2024
Q1
$111K Sell
13,070
-1,322
-9% -$14.7K 0.01% 992
2023
Q4
$150K Buy
14,392
+6,092
+73% +$48.5K 0.01% 953
2023
Q3
$53K Sell
8,300
-130
-2% -$960 ﹤0.01% 1183
2023
Q2
$73K Buy
+8,430
New +$75.5K ﹤0.01% 1174
2021
Q1
Sell
-2,756
Closed -$130K 1496
2020
Q4
$130K Hold
2,756
﹤0.01% 1229
2020
Q3
$128K Hold
2,756
﹤0.01% 1134
2020
Q2
$99K Buy
+2,756
New +$102K ﹤0.01% 1150

Other funds holding ZYME

Shell Asset Management's ZYME Position: Q3 2025 in Review

Shell Asset Management reduced its Zymeworks (ZYME) stake by 55% in Q3 2025, selling an estimated $72.8K and leaving 4,212 shares worth $72K. The position accounts for 0.01% of the portfolio, ranked #757.

Shell Asset Management first reported a position in ZYME in Q2 2020 and has held it in 12 quarters since. The position peaked at $181K in Q4 2024. 183 funds tracked by Wall St. Rank hold ZYME as of Q3 2025.

  • Shell Asset Management held 4,212 shares of Zymeworks worth $72K as of Q3 2025.
  • Shell Asset Management sold 5,084 Zymeworks shares in Q3 2025, an estimated $72.8K.
  • Zymeworks made up 0.01% of Shell Asset Management's portfolio in Q3 2025, its #757 holding.
  • Shell Asset Management first reported a position in Zymeworks in Q2 2020 and has held it in 12 quarters since.
  • Shell Asset Management's Zymeworks position peaked at $181K in Q4 2024.
  • 183 funds tracked by Wall St. Rank held Zymeworks as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.